- Announced that the Company is in receipt of advisory services and up to $500,000 in research and development funding from National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to complete final commercialization and mass production requirements for its Covid-19 technology, the Kontrol BioCloudTM analyzer
- Company has commenced initial production of BioCloud units for delivery in approximately 5 to 6 weeks. Initial deliveries include the sale of units to distributors and Kontrol customers.
- Further, the Company will deliver demonstration units to pilot customers in the Middle East.
TORONTO, ON / December 3, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“) is pleased to announce that the Company is in receipt of advisory services and up to $500,000 in research and development funding from National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to complete final commercialization and mass production requirements for its Covid-19 technology, the Kontrol BioCloudTM analyzer (“BioCloud analyzer” or “BioCloud“).
“This is another important accomplishment and milestone for Kontrol and represents the continuing advancement of the BioCloud technology,” says Paul Ghezzi, CEO Kontrol. “The focus of our BioCloud technology is to help create safe spaces for all as we collectively continue to face the challenge of the COVID-19 pandemic. We are thankful for this support from NRC IRAP.”
Production
The Company has commenced initial production of BioCloud units for delivery in approximately 5 to 6 weeks. Initial deliveries include the sale of units to distributors and Kontrol customers. Further, the Company will deliver demonstration units to pilot customers in the Middle East. The Company will announce those sales which are material and other sales will be reported in the applicable quarterly financial statements as ordinary course.
About Kontrol BioCloudTM
BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others.
Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com
BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus). Safe Space Technology is a Kontrol Trademark.
About Kontrol Energy
Kontrol Energy Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol Energy provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.
Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com
Tags: BioCloud, COVID-19, CSA, CSA Standards, CSE, energy conservation, google nest, small cap, small cap stocks